Humanin and colivelin: Neuronal-death-suppressing peptides for Alzheimer's disease and amyotrophic lateral sclerosis

CNS Drug Reviews

Volumn 12, Issue 2, 2006, Pages 113-122

  Matsuoka, Masaaki ^a   Hashimoto, Yuichi ^a   Aiso, Sadakazu ^a   Nishimoto, Ikuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloid; Alzheimer's disease; Amyotrophic lateral sclerosis; Colivelin; Humanin

Indexed keywords

ACTIVITY DEPENDENT NEUROTROPHIC FACTOR; COLIVELIN; HUMANIN; JANUS KINASE 2; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; PEPTIDE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL MEMBRANE; CONCENTRATION RESPONSE; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL;

EID: 33748049127     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2006.00113.x     Document Type: Review

References (54)

1. Brenneman DE, Gozes I. A femtomolar-acting neuroprotective peptide. J Clin Invest 1996;97:2299-2307.
2. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-749.
3. Caricasole A, Bruno V, Cappuccio I, Melchiorri D, Copani A, Nicoletti F. A novel rat gene encoding a humanin-like peptide endowed with broad neuroprotective activity. FASEB J 2002; 16:1331-1333.
4. Chiba T, Hashimoto Y, Tajima H et al. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo. J Neurosci Res 2004;78:542-552.
5. Chiba T, Yamada M, Hashimoto Y et al. Development of a femtomolar-acting Humanin derivative named Colivelin by attaching ADNF to its N terminus: Characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo. J Neurosci 2005;25:10252-10261.
6. Chiba T, Yamada M, Sasabe J, et al. Colivelin prolongs survival of an ALS model mouse. Biochem Biophys Res Commun 2006;343:793-798.
7. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806-819.
8. Czech C, Lesort M, Tremp G, et al. Characterization of human presenilin 1 transgenic rats: Increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience 1998;87:325-336.
9. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F•DP, in β-amyloid-induced neuronal death. J Biol Chem 1999;274: 19011-19016.
10. Gschwind M, Huber G Apoptotic cell death induced by β-amyloid I-42 peptide is cell type dependent. J Neurochem 1995;65:292-300.
11. Guo Q, Fu W, Sopher BL, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 1999;5:101-106.
12. Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003;423:456-461.
13. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001;29:166-173.
14. Harada M, Habata Y, Hosoya M, et al. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem Biophys Res Commun 2004;324:255-261.
15. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002;297:353-356.
16. Hashimoto Y, Niikura T, Ito Y, Nishimoto I. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J Biol Chem 2000;275:34541-34551.
17. Hashimoto Y, Niikura T, Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA 2001;98:6336-6341.
18. Hashimoto Y, Kaneko Y, Tsukamoto E, et al. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD. J Neurochem 2004;90:549-558.
19. Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci 2005;77:3092-3104
20. Hashimoto Y, Chiba T, Yamada M, et al. Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein. Mol Cell Biol 2005;25:9304-9317.
21. Hashimoto Y, Nawa M, Chiba T, Aiso S, Nishimoto I, Matsuoka M. Transforming growth factor beta2 autocrinally mediates neuronal cell death induced by amyloid-beta. J Neurosci Res 2006;83:1039-1047.
22. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J Neurochem 1995;65:2585-2593.
23. Kanekura K, Hashimoto Y, Kita Y, et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J Biol Chem 2005;280:4532-4543.
24. Kanekura K, Hashimoto Y, Niikura T, Aiso S, Matsuoka M, Nishimoto I. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J Biol Chem 2004;279:19247- 19256.
25. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S. Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 2002;13(6):903-907.
26. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003;301:839-842.
27. Kawasumi M, Hashimoto Y, Chiba T, et al. Molecular mechanisms for neuronal cell death by Alzheimer's amyloid precursor protein-relevant insults. NeuroSignals 2002;11:236-250.
28. Krejcova G, Patocka J, Slaninova J. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 2004;10:636-639.
29. Lane RM, Kivipelto M, Greig NH. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin Neuropharmacol 2004;27:141-149.
30. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993;90:7951-7955.
31. Luciano F, Zhai D, Zhu X, et al. Cytoprotective peptide humanin binds and inhibits proapoptotic Bcl-2/Bax family protein BimEL. J Biol Chem 2005 280:15825-15835.
32. Luo JJ, Wallace W, Riccioni T, et al. Death of PC12 cells and hippocampal neurons induced by adenoviral-mediated FAD human amyloid precursor protein gene expression. J Neurosci Res 1999;55:629-642.
33. Mamiya T, Ukai M. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 2001;134:1597-1599.
34. Niikura T, Yamada M, Chiba T, Aiso S, Matsuoka M, Nishimoto I. Characterization of V642I-A6421PP-induced cytotoxicity in primary neurons. J Neurosci Res 2004;77:54-62.
35. Niikura T, Chiba T, Aiso S, Matsuoka M, Nishimoto I. Humanin: After the discovery. Mol. Neurobiol 2004; 30:327-340
36. Nishimoto I, Matsuoka M, Niikura T. Unravelling the role of humanin. Trends Mol Med 2004;10:102-105.
37. Nishimura I, Uetsuki T, Dani SU, et al. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J Neurosci 1998;18: 2387-2398.
38. Pike CJ, Ramezan-Arab N, Cotman CW. Aβ-amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants. J Neurochem 1997;69:1601-1611.
39. Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Pillot T. Humanin rescues cortical neurons from prion-peptide-induced apoptosis. Mol Cell Neurosci 2004;25:95-102.
40. Storkebaum ED, Lambrechts M, Dewerchin MP, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005;8:85-92.
41. Sudo H, Hashimoto Y, Niikura T, et al. Secreted Aβ does not mediate neurotoxicity by antibody-stimulated amyloid precursor protein. Biochem Biophys Res Commun 2001;282:548-556.
42. Tajima H, Kawasumi M, Chiba T, et al. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res 2005;79:714-723.
43. Terashita K, Hashimoto Y, Niikura T, et al. Two serine residues distinctly regulate the rescue function of humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: Functional potentiation by isomerization and dimerization. J Neurochem 2003;85:1521-1538.
44. Tsukamoto E, Hashimoto Y, Kanekura K, Niikura T, Aiso S, Nishimoto I. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-β peptides via p75 neurotrophin receptor in neuronal hybrid cells. J Neurosci Res 2003;73:627-636.
45. Vande Velde C, Cleveland DW. VEGF: Multitasking in ALS. Nat Neurosci 2005;8:5-7.
46. Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci 1999;19:5360-5369.
47. Wolozin B, Iwasaki K, Vito P, et al. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science 1996;274:1710-1713.
48. Yamagishi Y, Hashimoto Y, Niikura T, Nishimoto I. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults. Peptides 2003;24:585-595.
49. Yamatsuji T, Matsui T, Okamoto T, et al. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 1996;272:1349-1352.
50. Yamatsuji T, Okamoto T, Takeda S, Murayama Y, Tanaka N, Nishimoto I. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J 1996;15:498-509.
51. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001;29: 160-165.
52. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245:417-420.
53. Ying G, Iribarren P, Zhou Y, et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 2004;172:7078-7085.
54. Zhao B, Chrest FJ, Horton Jr WE, Sisodia SS, Kusiak JW. Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J NeuroSci Res 1997;47:253-263.